Wensheng Qiu

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

Zhihao Lü, Junye Wang, Yongqian Shu et al. · BMJ · 2022 · 480 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With <i>RAS</i> Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial

Shukui Qin, Jin Li, Liwei Wang et al. · Journal of Clinical Oncology · 2018 · 257 citations · Full text

Medicine, Oncology, Pharmacology +12

Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial

Chang Liu, Zhi Peng, Yanqiao Zhang et al. · The Lancet · 2025 · 105 citations · Full text

Medicine, Oncology, Gastroenterology +8

Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer

Wensheng Qiu, Fang Zhou, Qian Zhang et al. · Apmis · 2013 · 72 citations

Medicine, Oncology, Pathology +15

MiR‐200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1

Yasai Yao, Jian Hu, Zan Shen et al. · Journal of Cellular and Molecular Medicine · 2015 · 70 citations · Full text

Life Sciences, Cancer Biology, Oncology +17